secwatch.observer — SEC 8-K summary
======================================

Issuer:     NantHealth, Inc. (—)
CIK:        0001566469
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001566469-23-000024
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NantHealth receives Nasdaq delisting notice for failure to meet public float requirement
--------------------------------------------------------------------------------

- Received Nasdaq notice on May 2, 2023 that common stock will be suspended on May 11, 2023 due to non-compliance with $15M public float requirement.
- Company intends to request a hearing by May 9, 2023, which will stay suspension pending Nasdaq hearing process.
- Previously disclosed deficiency from October 31, 2022; compliance period ended May 1, 2023.
- Stock continues to trade on Nasdaq Global Select Market under symbol NH during the appeal process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566469/000156646923000024/0001566469-23-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566469/000156646923000024/nh-20230502.htm
  HTML page:      https://secwatch.observer/filing/0001566469-23-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer